These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20666943)

  • 1. Clinical significance of serum Dkk-3 in patients with gynecological cancer.
    Jiang T; Huang L; Wang S; Zhang S
    J Obstet Gynaecol Res; 2010 Aug; 36(4):769-73. PubMed ID: 20666943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum DKK-1 in patients with gynecological cancer.
    Jiang T; Wang S; Huang L; Zhang S
    Int J Gynecol Cancer; 2009 Oct; 19(7):1177-81. PubMed ID: 19820386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum evaluation of P53 protein in patients with gynaecological cancer.
    Barbati A; Mariani L; Porpora MG; Anceschi M; Collini P; Lauro V; Cosmi EV
    Anticancer Res; 2000; 20(2A):1033-5. PubMed ID: 10810393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated serum globulin determined in patients with cervical, endometrial and ovarian cancer.
    Altarac S
    Acta Med Croatica; 1993; 47(1):19-22. PubMed ID: 7693081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay.
    Chien CH; Huang CC; Lin YH; Shen J; Chow SN
    Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
    Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P
    Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer.
    Jiang T; Huang L; Zhang S
    Int J Biol Markers; 2013 Jun; 28(2):221-5. PubMed ID: 23595579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.
    Kaiser M; Mieth M; Liebisch P; Oberländer R; Rademacher J; Jakob C; Kleeberg L; Fleissner C; Braendle E; Peters M; Stover D; Sezer O; Heider U
    Eur J Haematol; 2008 Jun; 80(6):490-4. PubMed ID: 18331598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel screening biomarker in gastric cancer: serum Dickkopf-1.
    Gomceli I; Bostanci EB; Ozer I; Kemik AS; Turhan N; Tez M; Kilic S; Demiriz B; Akoglu M
    Hepatogastroenterology; 2012; 59(117):1661-4. PubMed ID: 22155860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shed membrane fragment-associated markers for endometrial and ovarian cancers.
    Taylor DD; Lyons KS; Gerçel-Taylor C
    Gynecol Oncol; 2002 Mar; 84(3):443-8. PubMed ID: 11855885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
    Konno R; Takano T; Sato S; Yajima A
    Clin Cancer Res; 2000 Sep; 6(9):3576-80. PubMed ID: 10999747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin plasma levels in gynecological cancers.
    Grammatikakis IE; Botsis DC; Grigoriou OV; Dalamanga AN; Creatsas GC
    J BUON; 2010; 15(1):122-6. PubMed ID: 20414938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis.
    Daoussis D; Liossis SN; Solomou EE; Tsanaktsi A; Bounia K; Karampetsou M; Yiannopoulos G; Andonopoulos AP
    Arthritis Rheum; 2010 Jan; 62(1):150-8. PubMed ID: 20039407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum VEGF in women with ovarian tumors.
    Oehler MK; Caffier H
    Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with placental protein 4 (PP-4) as tumor marker in cervical and endometrial cancer.
    Göcze PM; Szabò DG; Than GN; Csaba IF; Keller G; Vahrson H; Bohn H
    Strahlenther Onkol; 1991 Sep; 167(9):538-44. PubMed ID: 1833844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
    Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
    Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum levels of immunosuppressive acidic protein in gynecological cancer].
    Sato S; Wakisaka T; Hamazaki Y; Oikawa N; Toki T; Yamauchi R; Sakahira H; Tase T; Yajima A; Suzuki M
    Gan No Rinsho; 1983 Jul; 29(8):897-9. PubMed ID: 6887522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.